News
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides effective protection against respiratory syncytial virus-related lower respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback